Clinical Trial Update: Impact of Antihypertensive Therapy on Recurrence Risk of Ovarian Cancer for Bevacizumab-associated Hypertension

View source ↗

Summary

A clinical trial update examining whether antihypertensive therapy affects recurrence risk in ovarian cancer patients receiving bevacizumab-related hypertension…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension
• Ovarian Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)

Snippet

Sponsor: Groupe Hospitalier Pitie-Salpetriere | Conditions: Ovarian Cancer, Antiangiogenic-Associated Hypertension | Status: ACTIVE_NOT_RECRUITING